Holmarc Opto (HOLMARC)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding is high at 62.69%, aligning management interests with minority shareholders.
• ROCE of 19.73% suggests the existing capital base has been reasonably productive despite the profit slump.
• Latest quarterly sales of ₹16 crore provide a revenue base that could support a recovery if margins improve.
• Market cap of ₹95 crore and 52-week range indicate a small, actively traded stock with potential upside if fundamentals turn.

Concerns

• Profit growth is down 85.48%, and latest quarterly net profit is ₹0 crore, meaning current earnings power is almost nil.
• P/E of 35.63 is expensive given collapsing earnings; the multiple offers no margin of safety.
• Piotroski F-Score of 3/9 points to weak financial health and possible operational stress.
• Book value, ROE, and debt/equity data are unavailable, making a proper Graham-style balance-sheet check impossible.

AI Analysis

When I look at Holmarc Opto, I try to see the business underneath the price. What do the numbers tell me? The company is a small industrial-products player with a market cap of just ₹95 crore. In the latest quarter, it generated ₹16 crore in sales but essentially no profit — net profit is ₹0 crore. Over the last year, profit collapsed 85.48%, and sales slipped 4.88%. That is not the picture of a thriving enterprise. At ₹94.50, the stock trades at 35.63 times earnings. But those earnings are near zero, so this multiple is almost meaningless. Graham taught me to demand a margin of safety: pay a price that leaves room for error. Here, the price leaves no room for error. The Piotroski score of 3/9 reinforces my concern; the financial health of the firm is weak. I cannot even check book value or return on equity because those figures are not disclosed. Inadequate data is a red flag for a small shareholder. On the positive side, promoters hold 62.69%, so their interests are aligned with mine. The return on capital employed is a respectable 19.73%, which tells me the existing capital base has been reasonably productive. But with sales falling and the latest quarter's profit at zero, that return is likely to deteriorate. The dividend yield of 0.42% is token. This is a possible turnaround, not a proven one. I do not invest based on possibilities; I invest based on evidence. The evidence today shows a business under stress, a weak financial score, and a price that offers no margin of safety. I would put Holmarc on the watchlist. If sales stabilise and profits return for a few consecutive quarters, I will reconsider. Until then, the arithmetic fails my test.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer